Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer - Related Studies

Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer

This study is currently recruiting participants.

Study NCT00079274. Last updated on November 28, 2008. Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Colorectal Cancer

2	Additional conditions recognized in this trial
		Colonic Neoplasms
		Colorectal Neoplasms

3	More general conditions related to this trial
		Colonic Diseases
		Digestive System Diseases
		Digestive System Neoplasms
		Gastrointestinal Diseases
		Gastrointestinal Neoplasms
		Intestinal Diseases
		Intestinal Neoplasms
		Neoplasms
		Neoplasms by Site
		Rectal Diseases

4	Interventions listed in this trial
		cetuximab
		fluorouracil
		irinotecan hydrochloride
		leucovorin calcium
		oxaliplatin

5	Additional drug interventions recognized in this trial
		Camptothecin
		Irinotecan
		Leucovorin

6	More general drug interventions related to this trial
		Antimetabolites
		Antimetabolites, Antineoplastic
		Antineoplastic Agents
		Antineoplastic Agents, Phytogenic
		Enzyme Inhibitors
		Growth Substances
		Immunologic Factors
		Immunosuppressive Agents
		Micronutrients
		Molecular Mechanisms of Pharmacological Action
		Pharmacologic Actions
		Physiological Effects of Drugs
		Therapeutic Uses
		Vitamin B Complex
		Vitamins

7	Sponsors listed in this trial
		North Central Cancer Treatment Group
		National Cancer Institute (NCI)
		Eastern Cooperative Oncology Group